*NEW BIOAVAILABLE DELIVERY SYSTEM
**SUBLINGUAL TAB (DISSOLVES UNDER THE TONGUE)
 
SLU-PP-332 is an experimental compound designed to mimic the metabolic effects of exercise without requiring physical activity. It functions as an agonist of estrogen-related receptors (ERRs), particularly ERR?, which play a crucial role in regulating energy metabolism. By activating these receptors, SLU-PP-332 enhances mitochondrial function and promotes the oxidation of fatty acids, leading to increased energy expenditure. In preclinical studies involving obese mice, administration of SLU-PP-332 resulted in significant weight loss�approximately 12% reduction in body weight�without altering food intake or physical activity levels. 
 
The compound's mechanism involves shifting the body's energy utilization towards fat oxidation, thereby reducing fat mass accumulation. Additionally, SLU-PP-332 has been observed to improve muscle function and endurance, as treated mice were able to run 50% further than untreated counterparts.  These findings suggest that SLU-PP-332 could serve as a potential therapeutic agent for weight loss and metabolic health improvement, especially for individuals unable to engage in regular physical exercise. However, it's important to note that SLU-PP-332 is still under investigation and has not yet been approved for clinical use in humans.